Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 All Aboard for the FY 18 Rollercoaster Ride Read More Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 House to Consider Appropriations Bill that Includes Ag/FDA Funding and more Read More Analysis and Commentary STEVEN GROSSMAN 8/11/17 Analysis and Commentary STEVEN GROSSMAN 8/11/17 It's Going to Get Tougher From Here Read More Advocacy at a Glance STEVEN GROSSMAN 8/11/17 Advocacy at a Glance STEVEN GROSSMAN 8/11/17 HHS Always “In Session” and more Read More Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More Advocacy at a Glance STEVEN GROSSMAN 8/4/17 Advocacy at a Glance STEVEN GROSSMAN 8/4/17 FDARA Clears Senate; Needs President’s Signature to Become Law and more Read More Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More Advocacy at a Glance STEVEN GROSSMAN 7/28/17 Advocacy at a Glance STEVEN GROSSMAN 7/28/17 House Passes First Appropriations Bill; Recesses Until September 5 and more Read More Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More Advocacy at a Glance STEVEN GROSSMAN 7/14/17 Advocacy at a Glance STEVEN GROSSMAN 7/14/17 More Good Progress; Still No Certainties Read More Advocacy at a Glance STEVEN GROSSMAN 7/14/17 Advocacy at a Glance STEVEN GROSSMAN 7/14/17 FDA Starts FY 19 Budget Planning Long Before FY 18 Process is Completed and more Read More Analysis and Commentary STEVEN GROSSMAN 6/30/17 Analysis and Commentary STEVEN GROSSMAN 6/30/17 Happier ... But Not Out of the Woods by Any Means Read More Advocacy at a Glance STEVEN GROSSMAN 6/30/17 Advocacy at a Glance STEVEN GROSSMAN 6/30/17 User fees in House Appropriations Bill Consistent With FDARA Numbers and more Read More STEVEN GROSSMAN 6/29/17 STEVEN GROSSMAN 6/29/17 Alliance Applauds House Ag/FDA Appropriations Subcommittee Read More Analysis and Commentary STEVEN GROSSMAN 6/23/17 Analysis and Commentary STEVEN GROSSMAN 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More Advocacy at a Glance STEVEN GROSSMAN 6/23/17 Advocacy at a Glance STEVEN GROSSMAN 6/23/17 CBO Score on Senate FDARA Bill Leads to Confusion About Unfunded Mandates and more Read More Analysis and Commentary STEVEN GROSSMAN 6/16/17 Analysis and Commentary STEVEN GROSSMAN 6/16/17 From Fantasy to a Potential Reality ... Maybe? Read More Advocacy at a Glance STEVEN GROSSMAN 6/16/17 Advocacy at a Glance STEVEN GROSSMAN 6/16/17 What FDA Deputy Commissioner Ostroff Said About Food Read More Analysis and Commentary STEVEN GROSSMAN 6/9/17 Analysis and Commentary STEVEN GROSSMAN 6/9/17 The Realities of the FY 18 Budget; Some Qs&As Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 All Aboard for the FY 18 Rollercoaster Ride Read More
Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 House to Consider Appropriations Bill that Includes Ag/FDA Funding and more Read More
Analysis and Commentary STEVEN GROSSMAN 8/11/17 Analysis and Commentary STEVEN GROSSMAN 8/11/17 It's Going to Get Tougher From Here Read More
Advocacy at a Glance STEVEN GROSSMAN 8/11/17 Advocacy at a Glance STEVEN GROSSMAN 8/11/17 HHS Always “In Session” and more Read More
Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/4/17 Advocacy at a Glance STEVEN GROSSMAN 8/4/17 FDARA Clears Senate; Needs President’s Signature to Become Law and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More
Advocacy at a Glance STEVEN GROSSMAN 7/28/17 Advocacy at a Glance STEVEN GROSSMAN 7/28/17 House Passes First Appropriations Bill; Recesses Until September 5 and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More
Advocacy at a Glance STEVEN GROSSMAN 7/14/17 Advocacy at a Glance STEVEN GROSSMAN 7/14/17 More Good Progress; Still No Certainties Read More
Advocacy at a Glance STEVEN GROSSMAN 7/14/17 Advocacy at a Glance STEVEN GROSSMAN 7/14/17 FDA Starts FY 19 Budget Planning Long Before FY 18 Process is Completed and more Read More
Analysis and Commentary STEVEN GROSSMAN 6/30/17 Analysis and Commentary STEVEN GROSSMAN 6/30/17 Happier ... But Not Out of the Woods by Any Means Read More
Advocacy at a Glance STEVEN GROSSMAN 6/30/17 Advocacy at a Glance STEVEN GROSSMAN 6/30/17 User fees in House Appropriations Bill Consistent With FDARA Numbers and more Read More
STEVEN GROSSMAN 6/29/17 STEVEN GROSSMAN 6/29/17 Alliance Applauds House Ag/FDA Appropriations Subcommittee Read More
Analysis and Commentary STEVEN GROSSMAN 6/23/17 Analysis and Commentary STEVEN GROSSMAN 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More
Advocacy at a Glance STEVEN GROSSMAN 6/23/17 Advocacy at a Glance STEVEN GROSSMAN 6/23/17 CBO Score on Senate FDARA Bill Leads to Confusion About Unfunded Mandates and more Read More
Analysis and Commentary STEVEN GROSSMAN 6/16/17 Analysis and Commentary STEVEN GROSSMAN 6/16/17 From Fantasy to a Potential Reality ... Maybe? Read More
Advocacy at a Glance STEVEN GROSSMAN 6/16/17 Advocacy at a Glance STEVEN GROSSMAN 6/16/17 What FDA Deputy Commissioner Ostroff Said About Food Read More
Analysis and Commentary STEVEN GROSSMAN 6/9/17 Analysis and Commentary STEVEN GROSSMAN 6/9/17 The Realities of the FY 18 Budget; Some Qs&As Read More
